Results ASOT January 2009December 2010 = 645 N° patients=359 N° ASOT’s >400 = 100 (28 %) Notes reviewed = 95/100 patients Where both ASOT and Anti DNAse B were performed simultaneously (No =194), results correlated in 88% Throat Swab performed in the group with ASOT >400 = 43/100 65 % patients with ASOT >400 were prescribed antibiotics Conclusions Nearly 1/5 of patients with positive streptococ...

this study was undertaken to determine the antibiotic sensitivity of 686 strains of hemolytic streptococci isolated at the school of public health, divi­sion of streptococcal studies, to five antibiotics in vitro. all of the strains were sensitive to penicillin, erythromycin, chloramphenicol and ampicillin. 27 (4%) of the strains, were resistant to tetracyclin. the clinical implications of this...

Effectively Managed by Remote Control? I this issue, Fine and colleagues (1) propose a solution to managing the ever-present threat of group A streptococcal (GAS) pharyngitis. Adult streptococcal pharyngitis continues to worry and perplex clinicians and public health authorities. Which patients require evaluation, and which require treatment? Answering these questions would not only improve car...

Twenty days after a streptokinase infusion given for myocardial infarction, a patient developed a group G streptococcal throat infection. Thirteen days later he presented with a serum sickness type illness and progressive renal failure. Renal biopsy showed crescentic glomerulonephritis.

We present a case of fatal 'malignant' necrotising streptococcal myositis in a previously healthy 39-year-old man. The infection was caused by Lancefield group-A haemolytic streptococcus highlights the clinical features and the necessity of prompt aggressive treatment.

That haemolytic streptococci of human origin produce a substance capable of liquefying human fibrin was first demonstrated by Tillet and Garner in 1933. The fibrin from patients recently recovered from haemolytic streptococcal infection was in many cases found to be resistant to the action of this fibrinolysin. and confirmed these preliminary observations, and demonstrated antifibrinoly-sin in ...

BACKGROUND The oral probiotic Streptococcus salivarius K12 has been shown clearly to antagonize the growth of Streptococcus pyogenes, the most important bacterial cause of pharyngeal infections in humans, by releasing two bacteriocins named salivaricin A2 and salivaricin B. Unpublished observations indicate that it can also antagonize the growth of other bacteria involved in acute otitis media....